Katie Thurston reveals her HER2-negative breast cancer is treated with hormone therapy instead of chemo, detailing her custom treatment plan.

Researchers evaluated current treatment patterns and clinical outcomes for patients with HER2-positive metastatic breast cancer.

Researchers have found new compounds that could be used to treat a common breast cancer that can be resistant to hormone ...

Fengting Yan, MD, PhD, discusses how her clinical practice is informed by data and guidelines available on testing in breast cancer.

“This new combination treatment offers an additional option for some people whose breast cancer has progressed despite previous hormone therapy, and who may benefit from a targeted approac ...

C, provided insights on what to consider when treating patients with HR+, HER2- breast cancer in the second line of treatment ...

Healthcare providers sometimes also recommend chemotherapy and hormone therapy. Outlook: Stage 1 breast cancer is also considered early-stage, localized cancer (the cancer hasn't spread outside of ...

The organization projected 319,750 new diagnoses in 2025, the most of any cancer type. Adjuvant endocrine therapy is a standard treatment option for hormone receptor-positive breast cancer ...

“To evaluate the outcome of breast cancer therapy in a patient, healthcare professionals typically assess factors like the size and stage of the tumour, lymph node involvement, hormone receptor ...

Jan. 22, 2025 — Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone ...